ArticleJournal of nanobiotechnology2017

mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.

Yan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.